# NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial

Study · id `cardio:ct-nct06511505` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06511505](<https://clinicaltrials.gov/study/NCT06511505>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06511505

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1000 participants.

## Technical summary

Registry record NCT06511505. Randomized; no masking; primary purpose screening. Start 2024-09-16 (actual); primary completion 2027-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose screening
- Phase: Not applicable
- Enrolled: 1000 participants (planned count; ClinicalTrials.gov record NCT06511505, source copy `cardio:ctgov-nct06511505-2026-08-20`, retrieved 2026-10-26)
- Started: 2024-09-16 (actual) (ClinicalTrials.gov record NCT06511505, source copy `cardio:ctgov-nct06511505-2026-08-20`, retrieved 2026-10-26)
- Primary completion: 2027-09 (anticipated) (ClinicalTrials.gov record NCT06511505, source copy `cardio:ctgov-nct06511505-2026-08-20`, retrieved 2026-10-26)
- Completion: 2028-09 (anticipated) (ClinicalTrials.gov record NCT06511505, source copy `cardio:ctgov-nct06511505-2026-08-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT06511505, source copy `cardio:ctgov-nct06511505-2026-08-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06511505-2026-08-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial
- Acronym: NOTABLE
- Condition: Atrial Fibrillation
- Condition: Cardiovascular Diseases
- Condition: Arrhythmia
- Condition: Valvular Disease
- Intervention (Device): Risk-Based Assessment for Cardiac Dysfunction
- Lead sponsor: Northwestern University
- Lead sponsor class: OTHER
- Collaborator: Tempus AI
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Northwestern University (`cardio:org-northwestern-university`)
- Registry lists this organization as a collaborator: Tempus AI (`cardio:org-tempus-ai`)

## Provenance

Content hash: e14e7649b5ca3e54283b03ac81f3d8466db55690fb79af9365d69133d8dd8004
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
